The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia

Our study suggests that the prevalent new-user design could be used for the assessment of clinical effects of DDIs.

Authors

Oriana Hoi Yun Yu (ORCID: https://orcid.org/0000-0003-4877-557X)
Samy Suissa (ORCID: https://orcid.org/0000-0002-1281-5296)
Wanqi Wang (ORCID: https://orcid.org/0000-0001-7424-9165)
Antonios Douros (ORCID: https://orcid.org/0000-0002-6005-4006)
Ying Cui (ORCID: https://orcid.org/0000-0003-4917-0919)

Institutions

Jewish General Hospital (CA)
McGill University (CA)
Charité - Universitätsmedizin Berlin (DE)

Publication Details

Journal: Pharmacoepidemiology and Drug Safety
Published: 2024-10-01
DOI: https://doi.org/10.1002/pds.70014
Citations: 5
Primary Topic: Pharmaceutical Practices and Patient Outcomes
Type: article
Field-Weighted Citation Impact: 1.72

Funders

McGill University
Deutsche Forschungsgemeinschaft
Canadian Institutes of Health Research

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia

Oriana Hoi Yun Yu, Samy Suissa, Wanqi Wang, Antonios Douros et al.

Oct 1, 2024

5 citations

Pharmacoepidemiology and Drug Safety

Pharmaceutical Practices and Patient Outcomes

1.72

article

The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia

Oriana Hoi Yun Yu, Samy Suissa, Wanqi Wang, Antonios Douros, Ying Cui

October 1, 2024article en

5 citations

Abstract

Our study suggests that the prevalent new-user design could be used for the assessment of clinical effects of DDIs.

Pharmacoepidemiology and Drug SafetyVol. 33(10)

Jewish General Hospital (CA), McGill University (CA), Charité - Universitätsmedizin Berlin (DE)

McGill University, Deutsche Forschungsgemeinschaft, Canadian Institutes of Health Research

Good health and well-being

Openalex Percentile: Top 15%

Pharmaceutical Practices and Patient Outcomes

1.72

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia — Oriana Hoi Yun Yu, Samy Suissa, et al. · Pharmacoepidemiology and Drug Safety (2024) | TGRS Research Map | TGRS